rs104894311
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003282.4(TNNI2):c.521G>A(p.Arg174Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R174W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003282.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNNI2 | NM_003282.4 | c.521G>A | p.Arg174Gln | missense_variant | 8/8 | ENST00000381911.6 | |
TNNI2 | NM_001145829.2 | c.521G>A | p.Arg174Gln | missense_variant | 8/8 | ||
TNNI2 | NM_001145841.2 | c.521G>A | p.Arg174Gln | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNNI2 | ENST00000381911.6 | c.521G>A | p.Arg174Gln | missense_variant | 8/8 | 2 | NM_003282.4 | A1 | |
TNNI2 | ENST00000252898.11 | c.521G>A | p.Arg174Gln | missense_variant | 7/7 | 3 | A1 | ||
TNNI2 | ENST00000381905.3 | c.521G>A | p.Arg174Gln | missense_variant | 6/6 | 3 | P4 | ||
TNNI2 | ENST00000381906.5 | c.521G>A | p.Arg174Gln | missense_variant | 8/8 | 3 | A1 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
Distal arthrogryposis type 2B1 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 01, 2015 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2003 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 05, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing [PMID: 23401156, 12592607, ClinVar ID: 12435] - |
Pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | Jan 23, 2019 | - - |
not provided Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 30, 2021 | Not observed in large population cohorts (Lek et al., 2016); Published functional studies demonstrate a damaging effect as R174Q results in increased calcium sensitivity (Robinson et al., 2007); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 12592607, 17194691, 23850728, 23401156, 30630514) - |
not provided, no classification provided | literature only | TNNI2 homepage - Leiden Muscular Dystrophy pages | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at